Rheumatoid Arthritis Clinical Trials in Phoenix

Showing 2281-2300 of 2,724 trials

Study of Electrical Impedance Myography (EIM) in ALS

NCT02011204

This trial is studying Electrical Impedance Myography (EIM) for measuring muscle health. The trial is studying people with Amyotrophic Lateral Sclerosis (ALS), other neuromuscular diseases, and healthy volunteers to see if the EIM device can measure disease in muscle tissue.

Amyotrophic Lateral SclerosisMotor Neuron DiseaseCharcot-Marie-Tooth Disease+1 more

Skulpt, Inc.106 participantsStarted Nov 2013

Phoenix, Arizona, United States • Miami, Florida, United States • Boston, Massachusetts, United States +3 more locations

WITHDRAWNPhase 2< 1 mile

Tocilizumab for Chronic Graft-versus-Host Disease Treatment

NCT02174263

This phase II trial studies how well tocilizumab works in treating chronic graft-versus-host disease (GVHD) in patients that have not responded to treatment after at least two prior therapies. Tocilizumab blocks a protein that stimulates the body's immune system. By blocking this protein, the investigators may reduce the symptoms of chronic GVHD.

Graft Versus Host Disease

Fred Hutchinson Cancer CenterStarted Feb 2016

Phoenix, Arizona, United States • Rochester, Minnesota, United States • Nashville, Tennessee, United States +2 more locations

Study of Electrical Impedance Myography (EIM) in ALS

Tocilizumab for Chronic Graft-versus-Host Disease Treatment

Rheumatoid Arthritis Trials in Other Cities

A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer

A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis

INFUSE®Bone Graft in Transforaminal Lumbar Interbody Fusion for Degenerative Disease of Lumbosacral Spine

GORE Flow Reversal System and GORE Embolic Filter Extension Study

An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis

VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid Arthritis

TearLab Core Validation Study to Establish Referent Values for Dry Eye Disease

Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic Sclerosis

A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis

Blood and Marrow Transplant Clinical Research Network

Intradiscal rhGDF-5 Phase I/II Clinical Trial

Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)

Efficacy Study of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0mg UPA for 24/4 Days

Early Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN-Omega Study)

Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 Study

The Complete® SE SFA Study for the Treatment of SFA/PPA Lesions

Long-term, Safety and Tolerability Study of AFQ056 in Adolescent Patients With Fragile X Syndrome (Open-label)

AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors

Other Conditions in Phoenix